Femasys Inc. (NasdaqCM: FEMY)
Health Care · Health Care Equipment & Supplies · US
$2.93
-1.01% today · -71.3% 1Y
Femasys Inc. (NasdaqCM: FEMY) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $24.79M and employs 53 people.
Over the last twelve months the share price has lost 71.3%, trading between 2.02 and 22.20.
Tweenvest scores Femasys Inc. across four factors: quality 18/100, value 56/100, growth 80/100. Its strongest factor is growth.
FEMY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.79M
- Revenue (TTM)
- $2.30M
- P/E
- —
- EPS
- -3.96
- Dividend yield
- —
- Beta (5Y)
- -2.09
- 52-week high
- $22.20
- 52-week low
- $2.02
- Avg volume (3M)
- —
- Shares outstanding
- 8.38M
- Employees
- 53
- Next earnings
- —
About Femasys Inc.
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer. Additionally, the company markets its FemVue saline-air device across various international regions, including the U.S., Europe, Canada, and Japan. Its infertility-related products are supplied to obstetrician-gynecologists, other allied healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. The company also offers a range of non-surgical product technologies.
- ISIN
- US31447E2046
- Founded
- 2004
- Listed since
- Jun 18, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $115.52 | -0.99% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $374.40 | +0.22% |
| Stryker CorporationNYSE: SYK | $125.74B | $326.09 | -0.52% |
| Medtronic plcNYSE: MDT | $118.91B | $91.31 | -1.71% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €160.20 | -0.93% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.20 | +0.39% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €39.65 | -1.83% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.